LRMR compared with NUVL: revenue, margins and what each company keeps, and the suppliers and customers both name

LRMRLarimar Therapeutics, Inc.

Mkt capRevenueRevenue

NUVLNuvalent, Inc.

Mkt capRevenueRevenue

Compare

LRMRLarimar Therapeutics, Inc.

NUVLNuvalent, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LRMR

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 4 '26±18.6%▲+3.27%×0.18

May 14 '26±21.5%▼−5.12%×0.24

Mar 19 '26±14.0%▲+3.95%×0.29

Jan 13 '26±99.8%▲+2.46%×0.03

NUVL

1 of 4at or beyond implied

Reportimpliedrealized× implied

May 7 '26±5.1%▼−1.78%×0.35

Feb 26 '26±8.0%▼−0.57%×0.07

= impliedLRMR realized, solidNUVL realized, hatchedOne scale, both sides: full bar = 100%× = |realized| ÷ impliedSource: market data

Oct 30 '25

±13.6%

▼−4.66%

×0.35

Aug 7 '25±6.4%▼−6.56%×1.03

LRMRLarimar Therapeutics, Inc.

2.39▼−3.24%· post 2.39

Mkt cap$256.6M

NUVLNuvalent, Inc.

123.96▲+0.02%· post 123.96

ClosedNov 2 '26

Mkt cap$9.8B

Compare

ClosedNov 2 '26

LRMRLarimar Therapeutics, Inc.

NUVLNuvalent, Inc.

2.39▼−3.24%post 2.39

Price

123.96▲+0.02%post 123.96

$256.6M

Mkt cap

$9.8B

LRMR2.39▼−3.24%vsNUVL123.96▲+0.02%ClosedNov 2 '26